Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Non-Current Assets (2018 - 2021)

Historic Non-Current Assets for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $32.6 million.

  • Black Diamond Therapeutics' Non-Current Assets rose 22557.21% to $32.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $75.5 million, marking a year-over-year decrease of 5110.8%. This contributed to the annual value of $10.1 million for FY2020, which is 29194.11% up from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Non-Current Assets of $32.6 million as of Q3 2021, which was up 22557.21% from $16.9 million recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Non-Current Assets high stood at $141.2 million for Q2 2020, and its period low was $142000.0 during Q4 2018.
  • Moreover, its 4-year median value for Non-Current Assets was $10.1 million (2020), whereas its average is $25.6 million.
  • Examining YoY changes over the last 5 years, Black Diamond Therapeutics' Non-Current Assets showed a top increase of 211924.69% in 2021 and a maximum decrease of 8800.68% in 2021.
  • Black Diamond Therapeutics' Non-Current Assets (Quarter) stood at $142000.0 in 2018, then surged by 1717.61% to $2.6 million in 2019, then surged by 291.94% to $10.1 million in 2020, then soared by 222.06% to $32.6 million in 2021.
  • Its Non-Current Assets stands at $32.6 million for Q3 2021, versus $16.9 million for Q2 2021 and $15.9 million for Q1 2021.